Pro Medicus Limited (ASX:PME – Get Free Report) insider Anthony Hall purchased 8,500 shares of the firm’s stock in a transaction dated Tuesday, February 24th. The shares were acquired at an average cost of A$110.13 per share, with a total value of A$936,105.00.
Anthony Hall also recently made the following trade(s):
- On Tuesday, December 23rd, Anthony Hall bought 2,270 shares of Pro Medicus stock. The stock was purchased at an average price of A$220.31 per share, with a total value of A$500,103.70.
- On Monday, December 22nd, Anthony Hall bought 2,250 shares of Pro Medicus stock. The shares were acquired at an average price of A$221.90 per share, with a total value of A$499,275.00.
Pro Medicus Stock Performance
The company has a current ratio of 5.98, a quick ratio of 4.39 and a debt-to-equity ratio of 1.10. The firm has a market capitalization of $29.16 billion, a P/E ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56.
Pro Medicus Dividend Announcement
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.
Further Reading
- Five stocks we like better than Pro Medicus
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
